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Summary: Seven enzymatic procedures for the determination of cholesterol in serum were compared with the
Liebermann-Burchard- and a gas-chromatographic method. Using a decision matrix all methods could be ranked
according to reliability and practicability. With the exception of the cholesterol oxidase-coupled Kageyama
principle and the Liebermann-Burchard procedure, all the other methods showed similar reliability.
Vergleich von 9 Methoden zur Bestimmung von Cholesterin
Zusammenfassung: Sieben enzymatische Verfahren zur Bestimmung der Cholesterin-Konzentration im Serum wur-
den mit der Liebermann-Burchard- und einer gaschromatographischen Methode verglichen. Mit Hilfe einer Entschei-
dungsmatrix wurde eine Wichtung von Ergebnissen und Praktikabilität versucht. Dabei zeigt sich, daß sich mit Aus-
nahme des mit Cholesterinoxidase gekoppelten Kageyama- und des Liebermann-Burchard-Prinzips die übrigen
Methoden etwa gleich zuverlässig verhielten.
Introduction
For many years, cholesterol was determined chiefly by
the Liebermann-Burchard and the Zak methods. Both
procedures are prone to various interferences, which are
summarized in several reviews (1—5). In addition, they
use a strong acidic milieu, a disadvantage which is partic-
ularly relevant in mechanised analytical systems, because
of corrosion.
After Richmond (6,7), in 1972, reported the isolation
of a bacterial cholesterol oxidase, various procedures
were sooft developed for the determination of chol-
esterol with the aid of this enzyme. In the meantime, in
many laboratories, the enzymatic methods have replaced
the older procedures mentioned above. They appear to
be more specific and better suited for mechanisation.
The various enzymatic methods differ with respect to
the coupled indicator reaction (table 1). After hydrolysis
of cholesterol esters in the presence of chofesterol
esterasej cholesterol oxidase activates the oxidation of
cholesterol to A4^cholestenon. The resulting H2O2 is
measured in most procedures.
For comparison, we selected 3 test kits based on Trinder's
reaction (8), but with differences in the reaction mixture,
one test kit applying the Hantzsch reaction according to
Kageyama (9), one test kit using the NADP-coupled alde-
hyde dehydrogenase reaction (10) and one test kit following
the principle first described by Harden & Helger (11). In
addition the Liebermann-Burchard procedure and a gas
Chromatographie method were included in this study. The
last method was primarily used to investigate the accuracy
of the other tests. In an earlier report we found, in accord-
ance with Attain et al. (12), that the procedure of A bell
et al. (13) often recommended for reference purposes,
leads to cholesterol values which are approximately 10%
higher than those determined with enzymatic methods.
Materials and Methods
Enzymatic methods
All enzymatic methods were performed with commercially
available test kits. The abbreviations used and some relevant
data are summarized in table 1. Concentrations of the various
components are listed in table 2 only for the Trinder principle,
because the test combinations chosen show significant differ-
ences. For further details, see the information distributed by
the manufacturers. All test kits were used as supplied by in-
dustry without further modifications. With the Kageyama
procedure the incubation period was extended to 75 minutes
according to I.e. (32). The ABA 100 and Labtronic ES 25 system
were set up as reported in table 3 and 4.
Liebermann-Burchard procedure
The Liebermann-Burchard reaction was performed with a SMA
12/60 from Technicon (Technicon GmbH, D-6368 Bad Vilbel)
0340-076X/79/0017-0553S02.00
©'by Walter de Gruyter & Co. - Berlin - New York
554 Haeckel, Sonntag, K lpmann and Feldmann: Comparison of 9 methods for the determination of cholesterol
Table 1: Methods for the determination of the cholesterol concentration
Method
number
1
2
3
Abbreviation
used
4-Aminophena-
zone (PAP)
Kageyama
Merckotest
Principle
ChO + ChE1)
and Trinder's
react ion (12)
ChO + ChE
and Kageyama's
principle (9)
ChO + ChE
Source
of
reagents
BM2)
BM2)
Merck3)
Cata-
logue
number
of test
kit
172626
124079
14350
Lot
number
of test
kit
Analyt-
ical
system
1277516 ES258)
64382501ES 258)
7500272 ES 25 8)
Meas-
uring
wave-
length
(nm)
Hg546
Hg405
Hg365
Incuba-
tion
temper-
ature
37
37
25
Incuba-
tion
time
(min)
15
75
30
Sample
volume
(Ml)
10
20
10
Aldehyde dehydro- ChO + ChE
gen se (A1DH) AlDH-method
according to
Haeckel &
Perlick (10)
ABA ChO + ChE
AlDH-method
according to
Haeckel & Perlick
(10)
GENT Chp+ChEand
Trinder's reaction
AA ChO + ChE
Technicon and
ES258) Hg334 37 10
4) ABA 340/380 37 10
100s)
SMA
GC
Winder's
reaction (12)
Lieber mann-
Burchard
Gas-chromato-
graphy
Abbott5) 6095 220 ABA 500/600 37 10
A1177N 100s)
Techni- T21- 1066102 AA II6) 525 37 9
con6) 0690-54 1327125
T21-
0888
Merz u. -
Dade7)
SMA room
12/606) 630 temper-
ature
Research9) - -
Gas
Chromato-
graph
5750
10
5
200
2000
200
^Cholesterol oxidase + cholesterol esterase. 2)·ΒΜ, Boehringer Mannheim (D-6800 Mannheim). 3) Merck AG (D-6100 Darmstadt)·
4) Reaction mixture was prepared according to I.e. (10). s) Abbott GmbH (D-6070 Langen) 6) AA II, cartridge No. 170-106-01 and
SMA 12/60, cartridge No. 157A058, Technicon GmbH (D-6368 Bad Vilbel). 7) Merz und Dade GmbH (D,8000 M nchen 50). 8) Lab-
tronic GmbH (D-6239 Vockenhausen) 9) Hewlett Packard (D-7030 B blingen).
Table 2: Contents of the assay mixture of test kits from various
manufacturers using the Trinder reaction.
table 3: Protocol of the ABA 100
Method1)
Potassium phosphate, m mo 1/1
pH
Phenol, mmol/1
4-Aminophenazone, mmol/1
Methanol, mmol/1
Hydroxypolyethoxydodecane, 9
Surfactant, %
Sodium cholate, mmol/1
Carbowax-6000, mmol/1
Peroxidase, U/l
Cholesterol oxidase, U/l
Cholesterol esterase, U/l
4-Amino-
phenazone
390
7.7
9.85
0.99
920.4
& 0.2
_
—
_
39
59
197
GENT
50
6.7
13.86
0.79
-
-
_
2.97
0.2
27393
165
116
AA
400
7.2
6.42
3.84
967.5
-
3.9
_
_
2260
191
136
J) For explanation of abbreviations see table 1
using method No. N-24 a. The reagents were purchased from
Merz und Dade (D-8000 Munich).
Gas chromatography
For gas chromatography we used the method of Siekmann et al
(14). The derivatisation was found to be unnecessary, and was
, omitted. Sample preparation: 200 μΐ serum and 1000 μΐ ΚΟΗ
Method No. 5 Method No. 6
ABA GENT
Temperature:
Mode:
time;
Reaction:
Filter:
C r usel revolutions:
Syringe plate:
Zero:
Calibrate:
Decimal point:
37°C
FR
10 min
up/rate
340/380
2
1:101
.000
.500
.000
37°C
NORM
10 min
up/endpoint
500/600
2
1:101
.000
.500
.000
(0.5 mol/1) in ethanol were incubated 30 min at 56°C. After
cooling to room temperature 6 ml cyelohexane were added. The
mixture was vigorously shaken for 5 min and then centrifugated
at 4000 r.p.rrh (5 min). Four ml of the cyelohexane phase was
evaporated and the residue dissolved in 100 μΐ + 1 ml) of which
2 μ\ were injected into a research gas Chromatograph 5750 G
equipped with a flame ionisation detector (Hewlett Packard,
D-6000 ^rankfurt/Main 56).
Conditions of the gas Chromatograph:
glass column 115 cm, column temperature 240°C, stationary
phase 3% OV-101 on* Gas Chrom Q, 100-120 niesh (Applied
J. Cliri.Chem. Clin. Biochem. / Vol. 17,1979/No. 8
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Table 4: Protocol of the Labtronic ES 25 System
Temperature
Filter
Computer
— programme
- factor
Photometer
- factor
Pipetter station
- position 1
syringe, μΐ
volume selected, μΐ
velocity
— position 2
syringe, μΐ
volume selected, μΐ
velocity
Method
No. 1
4-Aminophenazone
(PAP)
37° C
546
No. 3
22.1
S
1.00
2500
1000
10
50
10
10
Method
No. 21)
Kageyama
37° C
405
No. 4
33.9
S
1.00
Method
No. 3
Merckotest
25° C
365
No. 3
8.69
S
1.00
2500
2000
7
50
10
10
Method
No. 42)
Aldehyde dehydro-
genase
(A1DH)
37° C
334
No. 4
16.67
S
1.00
2500
1000
10
50
10
10
1) Pipetting was performed manually with Eppendorf pipets according to the manufacturer's instructions. This method uses a
sample blank without cholesterol oxidase.
2) 2 measurements, the first before and the second 10 minutes after the addition of 20 μΐ cholesterol oxidase. Mixing was performed
with a mini-mix (Vitatron GmbH, D-5000 K ln 60).
Science Lab. Inc., catalogue No. 12702, distributed by Serva
International, D-6900 Heidelberg), carrier-gas N2 (30 ml/min).
The cholesterol concentration of the unknown samples was
calculated from the regression line of the peak heights of stan-
dard solutions.
Standard solutions and calibration factors
Results were calculated with the factor supplied by the manu-
facturers for method 1—3.
With method No. 4 the coefficient of absorbance €334 nm =
6.18 Χ 106 cm2/mol (16) was used. Unter these conditions the
cholesterol standard (5.00 mmol/1) according to Richmond was
recovered almost 100% (x = 5.04, coefficient of variation 1.64%,
n = 28).
Method 5 and 6 were referred to a standard solution prepared
according to Richmond (15): 1450.02 mg cholesterol (purity
99%) were dried and dissolved in 50 ml propanol-2, of which
20 ml were combined with 15 ml Triton X-100 and then eva-
porated at 70°C under vacuum. The residue is transferred into a
100 ml volumetric flask with 40 ml hot, bidistilled water and
5 X 7 ml 200 g/1 albumin solution. At room temperature bi-
distilled water is added up to the 100 ml mark. One (or 2) ml
of this stock solution are mixed with 2 (or 1) ml of 70 g/1
albumin solution to give a solution containing 5 (or 10) mmol/1
cholesterol. This working standard solution is stable at 4°C for
one month. For the GC procedure cholesterol was drie4 and
directly dissolved in ethyl acetate. No significant difference was
found between the cholesterol used and standard material
supplied by the National Bureau of Standards (Washington,
D.C.,USA).
The working standard was also used s a control in all other
methods (except GC).
Method No. 7 was referred to Precilip.
Method No. 8 (Liebermann-Burchard, SMA 12/60) was referred
to Hyland reference serum (Travenol, DrSOOO Munich, cata-
logue No. HD 045-022, lot No. 3656N002BA). Under this
condition a value of 4.59 ± 0.1 mmol/1 (n = 28) was found m the
cholesterol standard according to Richmond.
Interference study
The test for interference was similar to that proposed by Staehler
et al. (17). Ten or 100 ml of a large serum pool were mixed with
the substance of interest as indicated in table 9. These samples
were analyzed in various series together with several control
samples (no substance added). The results from the control
samples were used to calculate the mean and the ± 3.s-range
(s = standard deviation). Bilirubin interference was studied by
dissolving 6 mg bilirubin (E. Merck AG, catalogue No. 24519)
in 500 μΐ bidist. H2O and 25 μΐ NaOH (1 mol/1). When the bili-
rubin was completely dissolved, albumin (70 g/1) was added to
2 ml. An aliquot (100 μΐ) of this solution was mixed with
1000 μΐ serum. Bilirubin was omitted in the control experiments.
Reagents
Propanol-2 (catalogue No. 9634), cholesterol (No. 24622),
ethyl acetate (No. 9623) and cyclohexane (No. 2828) were
purchased from E. Merck AG (D-6100 Darmstadt), Triton X-100
(No. 37238) from Serva (D-6900 Heidelberg), albumin (No.
ORDH) from Behringwerke AG (D-3550 Marburg), concen-
trated acetic acid (No. 33209) from Riedel de Haen (D-3016
Seelze) and KOH in ethanol from Boehringer Mannheim
(D-6800 Mannheim, catalogue No. 15916).
Control materials
Precilip (catalogue No. 125059) and Preciset (catalogue No.
125512) were purchased from Boehringer Mannheim (D-6800
Mannheim), Seronorm (catalogue No. NYCO 350053) from
Dr. Molter GmbH (D-6900 Heidelberg).
Statistical methods
The results of the correlation study were computed by main
component analysis (18,19). Serum samples were randomly
selected from patients of our hospital. Other statistical methods
were used according to l.c (20).
Results
Imprecision
The GC and Kageyama methods had the highest im-
precision from day to day (tab. 5), followed by the
SMA procedure, whereas all enzymatic methods had
j. Clin.Chem. Clin. Biochem. / Vol. 17, 1979 /No. 8
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Table 5: Precision from day to day of the various methods for the determination of the cholesterol concentration.
Control material
(Lot number)
Standard solution
Preciset (1067544)
Seronorm (128)
Precilip (455 A)
Kontrollogen L (452 A)
Assigned
value
(mmol/lj
(range)
5.00
3.88
2.802)
(2.49-3.11)
3.541)
(3.04-4.04)
4.002)
(3.44-4.56)
3.511)
(2.84-4.03)
3.672)
(3.13-4.21)
3.413)
(3.02-3.80)
4-Amino-
phena-
zone
(PAP)
5.034)
2.1
(28)
4.07
1.8
(28)
2.25
2.3
(30)
3.83
3.1
(30)
3.27
2.5
(30)
Kage-
yama
5.45
7.0
(28)
4.25
7.4
(28)
2.41
12.5
(30)
3.84
8.4
(30)
3.84
7.7
(30)
Mercko-
test
4.94
1.4
(28)
4.06
2.1
(28)
1.81
2.8
(30)
3.44
2.5
(30)
3.10
2.1
(30)
Alde-
hyde
dehydio-
genase
(AIDH)
5.04
1.5
(28)
4.17
2.8
(28)
2.25
1.0
(14)
3.49
2.6
(30)
3.34
1.9
(30)
ABA '
_
4.16
1.9
(28)
2.28
2.9
(30)
3.71
2.2
(14)
3.35
1.3
(30)
GENT
—
4.23
3.2
(28)
2.39
1.4
(30)
3.85
2.0
(30)
3.64
1.1
(30)
AA
5.39
1.5
(28)
3.96
2.3
(28)
2.14
1.2
(30)
-
3.21
1.9
(30)
SMA
4.59
2.9
(28)
3.48
2.9
(28)
2.64
4.0
(30)
3.92
3.0
(30)
3.76
2.6
(30)
GC
4.20
6.15
(8)
2.26
11.4
(9)
3.76
14.2
' (5)
*) for Kageyama method
2) for SMA-method
3) for 4-aminophenazone (PAP)-method
4) mean value, coefficient of variation (number of contributing values)
almost the same, good precision under the experimental
conditions chosen, with a mean coefficient of variation
of about 2.0%.
Accuracy
The relation between various cholesterol concentrations
and the absorbance difference obtained (linearity-test)
was checked with dilutions from the stock standard
solution. No relevant deviation (< 1 %) in the range in-
vestigated (up to 15 mmol/1) was seen with the 4-amino-
phenazone, Merck, aldehyde dehydrogenase and ABA
method. The range of linearity was slightly reduced with
the Kageyama (13 mmol/1), GENT (12 mmol/1), ISM A
(13 mmol/1), AA (10 mmol/1) and GC (12 mmol/1)
method.
For the intermethod comparison the GC method was
included in this study as a non-enzymatic procedure of
relatively high specificity. The correlation data are
summarized in table 6. All enzymatic procedures
showed a similar correlation with the GC-method; the
highest negative bias was obtained with the Merckotest
method.
For graphical presentation of the correlation data the
GC method is less suited because of its high imprecision
(table 5). For this purpose we preferred the 4-amino-
phenazone method (method No. 1 in table 1) whicfr is
now mostly applied in clinical chemistry. Its correlation
with the GC-method is shown in table 6 and figure 1.
Under these conditions the 4^arninophenazone method
correlated well (tab. 7> fig. 1) with the Merckotest, aide-
Table 6: The correlation between the GC method (x - values) and all other procedures (yj-values) for the determination of the
cholesterol concentration in sera from various patients. All figures were calculated by principle component analysis
according to I.e. (18).
Method a (intercept) b (slope) n (pairs of results)
4-Aminophenazone (PAP)
Kageyama
Merckotest
Aldehyde dehydrogenase (AIDH)
ABA
GENT
AA
SMA
-0.205
+ 0.211
- 0.435
-0.313
-0.339
+ 0.032
- 0.042
+ 1.220
1.040
1.045
1.039
1.048
1.057
1.027
1.007
0.803
0.963
0.875
0.952
• 6.946
0.939
0.952
0.953
0.855
115
115
115
115
115
115
115
109
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Table 7: The correlation between the 4-aminophenazone (PAP) method (x-values) and all other procedures (yj-values) for the
determination of the cholesterol concentration in sera from various patients. All figures were calculated by principle
component analysis according to I.e. (18).
Method
Kageyama
Merckotest
Aldehyde dehydrogenase
(A1DH)
ABA
GENT
AA
SMA
GC
X
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.75
y
5.20
4.56
4.72
4.96
4.73
4.79
5.09
4.76
a (intercept)
-0.28
-0.28
-0.08
+ 0.17
-0.18
+ 0.15
+ 1.01
+ 0.38
b (slope)
1.141
1.009
1.000
0.997
1.023
0.967
0.850
0.922
r
0.893
0.983
0.982
0.981
0.975
0.988
0.894
0.963
η
165
165
165
165
164
165
159
115
hyde dehydrogenase, ABA, GENT, AA and GC procedures.
The correlation with the Kageyama and SMA cannot be
accepted. With Merckotest the arithmetic mean for the
results from all patients was lower than with the 4-
aminophenazone method. The histogram in figure 2 shows
that this effect is not simply due to a parallel shift of the
whole distribution pattern by a constant negative bias.
In addition, with some control sera, the Merckotest led
to the lowest mean values, whereas with standard
solutions the recovery was comparable to those of the
other enzymatic procedures.
The esterase reaction was not actually tested. However,
the good correlation between the Liebermann-Burchard
or the GC method with its alkaline saponification step,
and the other procedures using the enzymatic hydroly-
sis, indicates that the esterase action may have been
sufficient in all tests used. The differences observed with
control materials (table 5) could be explained by the
various esterase sources which are chosen by the manu-
facturers.
Interference from endogenous substances
Assuming that the GC method is not disturbed by ele^
vated serum concentrations of triglycerides, hemoglobin
or bilirubin, the results of this procedure were compared
with all other methods. In figure 3 the difference (in
mmol/1) between both methods was plotted against the
serum concentration of bilirubin. In the case of an inter-
ference the regression line should be above or below
the middle line and have a slope. The ± 3 standard deviation
line was calculated from the results obtained with sera
which looked clear and were not considered to be cont-
aminated by one of the three endogenous substances.
No interference was noticed from hemoglobin (up to a
concentration of 7 gA), or from turbidity caused by tri-
glycerides (up to 12 mmol/1) under the conditions re-
ported in figure 3.
Zak (3) mentioned the potential reaction of bilirubin
with peroxide which could lead to an underestimation in
procedures using an indicator reaction for Η2θ2· How-
ever, a distinct disturbance by bilirubin was only noticed
with the Liebermann-Burchard method (fig. 3). This
overestimation of the cholesterol concentration in the
presence of bilirubin is well known. In the presence of
very high bilirubin levels added to 2 different sera
(tab. 8), the 4-aminophenazone method appeared to
slightly underestimate, and the Merck method to slightly
overestimate, the cholesterol concentration.
Uric acid (up to 2000 μηιοΐ/ΐ) did not influence the
cholesterol value in the enzymatic procedures.
Interferences from exogenous substances
50 various substances which represent the most common
used drugs and anticoagulants (17, 20) were added in
high, but relevant doses to pooled sera from several
patients (tab. 9).
The anticoagulants did not interfere with any of the
methods. No interferences were observed with the
Kageyama (No. 2), aldehyde dehydrogenase (No. 4)
and Liebermann-Burchard method (No. 8). Interferences
with the SMA and Kageyama procedures could have
been masked by the higher imprecision of these methods.
The other methods were submitted to a further study in
which the concentrations of the interfering substances
added were varied (table 10). Most often the cholesterol
concentration was underestimated. With hostacyclin an
overestimation was observed with the Merckotest
procedure (table 9 + 10). The recovery of cholesterol in
the presence of ascorbic acid and especially of a-methyl-
dopa was higher with the Merckotest than with other
methods using Trinder's principle. The interference of
ascorbic acid with Trinder's reaction is already known
(23).
Practicability
The Liebermann-Burchard method has the disadvantage
that it uses a strong acidic reaction medium. The
Kageyama procedure has the most pipetting steps. The
J. Clin. Chem. Clin. Biochem. / Vol. 17,1979 / No. 8
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_L JL
100 200 300
Bilirubin [μπηοΐ/l]
400 500
Fig. 3. Interference from bilirubin. The cholesterol concentration
in various bilirubmemic sera was determined with the GC
and the SMA methods. The difference (Δ cholesterol)
between the GC and the other method is plotted on the
ordinate. The upper and lower borderline were calculated
as the threefold standard deviation from the results (Δ
cholesterol) obtained with clear (non-bilirubinemic) sera
(n, see table 7).
other methods, except for GC, are equally practicable,
since all reagents can be combined into one mixture and
cholesterol oxidase be used to start the reaction. In the
aldehyde dehydrogenase method, the well known ab-
sorption coefficient of NAD(P)H can be used to calculate
the result.
The aldehyde dehydrogenase method requires either a
sample blank, a first absorbance reading before the
reaction has been started, or a kinetic measurement,
which is a disadvantage with manual procedures.
Conclusion
In table 11 a decision matrix is established by weighting
the results reported above. From this all methods could
be ranked. As expected the lowest rank was obtained
with method No. 2 arid 8.
Table 8: The influence of high bilirubin concentrations added to 2 different sera on various enzymatic procedures for the cholesterol
determination. All figures are mean values (mmol/1) from 2 determinations.
Serum number
Bilirubin, μιτιοΐ/l
4-Aminophenazone (PAP)
Merck
ABA
Aldehyde dehydrogenase
(A1DH)
1
11
3.64
3.63
3.90
3.90
1
390
3.50
3.78
3.87
3.88
% of control
96.1
104.1
99.2
99.5
2
12
3.60
3.28
3.62
3.54
2
792
3.10
3.50
3.61
3.55
% of control
86.1
106.7
99.7
100.3
Table 9: Recovery of cholesterol in human pooled sera containing various drugs. In the absence of any substance added a mean value
and the range of 3 standard deviations was calculated from 15 determinations of the cholesterol concentration. Values out*
side this range are considered as due to interference (marked by an asterisk).
Trade name I.N.N.1) Concentration
(mg/1)
Cholesterol concentration (mmol/1)
PAP Kageyama Mercko- A1DH ABA
test
GENT AA SMA
Amuno
Butazolidine
Metalcaptase
Prolixan
Resochin
Tanderil
Aponal
Megaphen
Multum
Aspirin „
Dolviran
Novalgin2)
Benemid
Uriovac
Zyloric
indometacinum
phenylbuta-
zonum
£-penicil-
laminum
azopropazon-
dihydrat
chloroquinum
oxyphenbuta-
zonum
doxepinum
phenothiazinum
chlordiazepo-
xidum
acidum acety-
losalicylicum
acidum acetylo-
salicylicum, etc.
novaminsul-
fonum
probenecidum
30
280
960
250
60
600
150
150
160
750
780
900
260
• benzbromaronum 60
allopurinolum 250
5.
5.
5.
5.
5.
5.
35
37
12
39
37
48
5.53
5.41
5.37
5.39' '
5.69
4.44*
5
5
5
.61
.66
.55
5.83
4.75
6.54
6.17
7.05
4.71
6.24
6.10
4.64
6.03
4.98
6.13
5.70
5.09
5.97
5.22
5.20
4.68*
5.05
5.23
5.01
5.27
5.10
5.14
5.15
5.14
1.05*
5.25
5.24
4.99
5.34
5.34
5.47
5.36
5.70
5.58
5.38
5.47
5.39
5.26
5.24
5.20
5.38
5.38
5.49
5.38
5.38
5.42
5.67
5.42
5.42
5.31
5.37
5.47
5.53
5.40
5.64
5.33
5.40
5.42
5.70
5.73
5.55
5.64
5.65
5.49
5.66
5.55
5.64
5.70
5.75
4.61*
5.70
5.62 ·
5,62
5.68
5.75
5.64
5.73
5.80
5.55
5.60
5.70
5.46
5.68
5.64
5.21*
5.68
5.70
5.55
6.6
6.8
6.7
6.8
6.6
6.9
7.0
6.4
6.3
7.0
5.7
6.5
6.7
6.5
6.6
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Table 9: (continued)
Trade name
Angiograftn
BÜigrafin
Urografin
Binotal 500
Hostacyclin
Paraxin
Refobacin
Buscopan
Cebion
Polybion
Dipar
Euglucon 5
Rastinon
Dulcolax
Durenat
Endoxan
Methotiexat
Intensain
Furadantin
Lanicor
Lasix
Luminal
Macrodcx 6%
Modenol
Presinol
Nicobion
Novadral
Solu-Decortin
Marcumar
Na-Citrat
Liquemin
Na-Fluorid
Na-Oxalat
EDTA
Aldactone
l.N.N. * ) Concentration
img/1)
acidum triiod- 2600
bcnzoicum
adipinyltriiod- 1200
anil id u m
acidum triiod- 1500
benzoicum
aminobenzyl· 900
penicillinum
tetracyclinum 200
chlorampheni- 600
col u m
gentamycinurn 1 20
hyoscin-N-butyl- 300
brominum
acidum 400
ascorbicum
Vitamin B 12.9
complex
phenylethyl- 220
biguanidc
glibenclamidurn 32
tolbutamidum 480
bisacodylum 40
sulfanuamido- 231
pyrimidinum
cyclophosphami-240
dum
acidum methyl· 500
pteroylglutami-
nicum
carbocromenum 900
nitrofurantoinum 98
digoxinum 0.1
furosemidum 60
acidum phenyl- 352
aethylbarbituricum
dextranum 6% 6000
thiabutazide, etc. 440
methyldopa 400
nicotinamidum 40
norfenefrinum 2.4
prednisolonum 8
phenprocoumo- 80
num
Na-citrate 5000
Na-heparinat 750
Na-fluoride 2000
Na-oxalate 2000
Titriplex 1000
spirolactonum 20
PAP
5.57
5.39
5.08
5.61
5.57
5.50
5.46
5.41
3.01*
5.35
5.75
5.44
5.22
5.70
5.72
5.68
5.59
5.44
5.26
5.26
5.35
5.37
5.62
5.39
3.05*
5.50
5.17
5.24
5.37
5.24
5.38
5.41
5.37
5.53
5,57
Kageyama
4.61
6.27
4.81
6.27
4.64
6.71
6.92
4.78
5.66
6.00
5.59
5.36
4.71
4.88
5.02
5.59
6.13
4.88
4.37
5.25
4.95
5.42
6.38
6.44
6.61
6.24
5.72
6.10
6.03
5.76
6.24
6.58
7.12
6.47
6.10
Cholesterol concentration (mmol/1)
Mercko-
test
5.23
5.23
5.19
4.41*
5.69*
5.06
5.07
5.22
3.45*
5.20
5.23
5.14
4.97
5.13
5.13
5.23
5.08
5.17
5.17
5.17
5.12
5.13
5.17
5.11
4.51*
5.09
5.19
5.23
5.13
5.20
4.98
4.95
5.10
5.20
5.24
A1DH
5.58
5.20
5.68
5.39
5.02
5.30
5.28
5.39
5.30
5.13
5.24
5.22
5.45
5.30
5.07
5.22
5.32
5.45
5.24
5.41
5.68
5.36
5.32
5.38
5.53
5.30
5.39
5.58
5.41
5.32
5.55
5.47
5.43
5.02
5.39
ABA
5.38
5.42
5.47
5.47
5.29
5.49
5.55
5.44
5.56
5.44
5.38
5.38
5.44
5.38
5.36
5.36
5.39
5.42
5.47
5.47
5.40
5.42
5.37
5.42
5.48
5.42
5.46
5.48
5.37
5.42
5.37
5.42
5.40
5.40
5.29
GENT
5.62
5.66
5.59
5.68
5.62
5.60
5.65
5.72
4.03*
5.64
5.73
5.70
5.63
5.77
5.73
5.73
5.58
5.73
5.73
5.73
5.65
5.64
5.59
5.53
3.72*
5.71
5.65
5.65
5.51
5.60
5.60
5.63
5.64
5.73
5.73
AA
5.70
5.75
5.69
5.67
5.65
5.68
5.72
5.79
3.16*
5.67
5.63
5.49
5.71
5.71
5.65
5.72
5.68
5.63
5.57
5.54
5.47
5.54
5.51
5.67
3.00*
5.68
5.67
5.68
5.63
5.61
5.65
5.61
5.57
5.63
5.68
SMA
6.8
7.1
6.6
7.3
6.0
6.5
6.3
6.9
7.5
6.0
5.9
6.2
6.8
6.0
6.2
5.8
6.5
6.0
5.6
6.0
5.7
6.6
5.5
7.1
7.0
6.3
6.5
6.6
6.3
7.3
7.1
6.7
7.3
6.8
6.6
*) International non-proprietary names as proposed by the WHO (21).2) Data are not considered in table 10, since clinically not relevant. This substance is rapidly metabolized and cannot be measured in
significant blood concentrations (25).
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Table 10: Interference in enzymatic procedures for the determination of cholesterol by varying concentrations of certain substances.
Method PAP Merckotest GENT AA
Interfering Substance
Ascorbic acid up to 0,7 mmol/11)
(overdosage up to 1.4) (24)
Presinol up to 193 mg/11) (26)
Binotal up to 300 mg/11)
(28,29)
Hostacyclin up to 8 mg/11)
(28,29)
Metalcaptase up to 10 mg/11)
(30,31)
Concentration in the sample Cholesterol
(mg/1) (mmol/1)
0
50 (0.28 mmol/1)
100 (0.5 7 mmol/1)
200 (1.14 mmol/1)
300 (1.70 mmol/1)
400 (2.27 mmol/1)
0
50
100
200
300
400
o
200
400
600
900
0
5
10
20
50
200
0
10
50
100
500
5.42
4.95
4.38
4.33
4.04
3.14
5.42
5.06
4.69
3.96
3.18
2.72
4.97
4.79
4.48
4.37
4.13
3.49
4.97
4.94
4.87
4.54
4.27
4.24
4.97
"4.42
3.45
2.64
2.27
5.42
5.42
5.46
5.49
5.65
5.98
5.42
5.36
4.54
4.64
3.99
5.80
5.53
5.1?
5.09
4.89
4,24
5.80
5.49
5.13
4.45
3.63
3.18
5.60
5.23
4.76
4.67
4.40
3.68
5.60
5.16
4.80
4.03
3.26
2.78
J) Serum concentration under therapeutic conditions.
Table 11: Comparison of the various methods by weighting the quantitative data from table 3-6 and figure 3.
Method 1 2 3 4 5 6 7 8
PAP Kageyama Mercko- AIDH .ABA GENT AA SMA
test
Precision1) + + + + + + + + + + + + +
Correlation2) + - + + + + + _
Linearity + + + + + + + + + + + +
Accuracy3) ++ + + ++ ++ ++ ++ _
Lack of interference + + + + + + + _
from bilirubin
Lack of interferences
from exogenous sub- ++ (+++) ++ +++ +++
stances4)
Practicability +++ + +++ ++ +++
Sum of plus signs 13 7 12 13 14 12 12
x) Coefficient of variation <3%++, < 5% +, > 5% -
2) r2 > 95.0% +, < 95.0% - (coefficient of determination, taken from I.e. (18))
3) estimated from table 5, 6 and 7
4) Table 9: no interference +++, interferences from < 3 substances ++, from more than 3 substances +
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